Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 19, 2026 03:00 ET | Source: Syncona Investment Management Limited (“SIML”)

Syncona Investment Management Limited highlights progress translating frontier science into therapeutic reality at Capital Markets Day

Syncona’s maturing portfolio entering a period of significant clinical and strategic milestones, positioning the business for near-term value creation and enabling returns to shareholdersHigh-calibre...
March 18, 2026 08:00 ET | Source: Amphista Therapeutics

Amphista Therapeutics appoints Louise Modis Ph.D. as CEO and Patrick Kelly M.D. as CMO and provides a business update as the Company prepares to file IND application for AMX-883

Strengthening the clinical leadership as the Company progresses to the clinic with its BRD9 Targeted Glue™, AMX-883, in acute myeloid leukemiaAmphista continues to advance its SMARCA and TEAD...
March 11, 2026 04:30 ET | Source: Commit Biologics

Commit Biologics appoints serial biotech founder as new CEO to take complement-powered immune engagers into the clinic

Commit Biologics appoints seasoned biotech entrepreneur Thomas L. F. Montgomery Andresen, PhD, as Chief Executive Officer.
March 11, 2026 03:00 ET | Source: Wolters Kluwer N.V.

Wolters Kluwer nominates Maarten de Vries for appointment to the Supervisory Board

Wolters Kluwer today announced the nomination of Maarten de Vries for appointment to its Supervisory Board.
March 10, 2026 03:00 ET | Source: Vect-Horus

Vect-Horus nomme Claudia Fromond au poste de Directrice de la Recherche et Développement

Vect-Horus a annoncé aujourd’hui la nomination de Claudia Fromond, PhD, en qualité de Directrice de la Recherche et Développement (R&D).
March 10, 2026 03:00 ET | Source: Vect-Horus

Vect-Horus appoints Claudia Fromond as new Director of R&D

Vect-Horus today announced the appointment of Claudia Fromond, PhD, as Director of Research and Development (R&D).
March 06, 2026 08:35 ET | Source: High Roller Technologies, Inc.

High Roller Announces Appointment of Andrew Walter as Chief Legal and Compliance Officer

Las Vegas, Nevada, March 06, 2026 (GLOBE NEWSWIRE) -- High Roller Technologies (“High Roller” and the “Company”) (NYSE: ROLR) today announced the appointment of Andrew Walter as Chief Legal and...
February 27, 2026 06:31 ET | Source: Wolters Kluwer N.V.

Stacey Caywood has officially assumed the role of CEO at Wolters Kluwer

Stacey Caywood has officially assumed the role of CEO at Wolters Kluwer
February 17, 2026 04:00 ET | Source: Oculis Holding AG

Oculis Appoints Katie Kazem as Chief Legal Officer

Ms. Kazem brings extensive and global expertise in corporate governance and securities law, drawing on a distinguished track record as external legal counsel to leading life sciences companiesChief...
February 10, 2026 08:00 ET | Source: OKYO Pharma LTD

OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer

Dr. Mantelli, former Chief Medical Officer at Dompé, spearheaded the successful clinical development program and FDA approval of Oxervate®, a blockbuster orphan therapy in corneal diseaseDr. Mantelli...